Product development
Product structures are developed around controlled manual needle retraction and single-use disablement.
About Xingxu Kangda
Shaanxi Xingxukangda Medical Technology Co., Ltd. develops and manufactures sterile retractable safety syringes and related automated production solutions.

Company profile
Xingxu Medical Devices (Suzhou) Co., Ltd. was established in 2016. A manufacturing operation was established in Lintong, Shaanxi in 2023, where Shaanxi Xingxukangda Medical Technology Co., Ltd. focuses on safety syringe development and production.
The operation integrates product research, precision molds, automated assembly equipment, cleanroom process design and international B2B supply.
Integrated company scope
Xingxu Kangda brings several connected capabilities together around retractable safety syringe development and manufacturing.
Product structures are developed around controlled manual needle retraction and single-use disablement.
Mold development supports the geometry and repeatability required by syringe components.
Assembly equipment and process design connect product development with scalable manufacturing.
Product information, videos and available documents support distributor and institutional evaluation.
Working principles
The company profile is strengthened by showing how technical and commercial discussions are approached.
Product conversations begin with structure, capacity, needle specification and intended market.
Available product videos, certificates and patent documents are presented for direct review.
Buyers can reach the product team through the inquiry form, email or WhatsApp.
Public records in China
The following milestones link to Chinese corporate, media and regulatory records. Planned capacity and project figures are presented as reported at the time, not as current supply commitments.
Public corporate information records Shaanxi Xingxukangda Medical Technology Co., Ltd. as established in Xi'an on 3 April 2023.
Corporate registration recordA Lintong media report stated that phase one of the Xingxu medical-engineering project entered production with two safety-syringe lines.
View public source ↗2024.1003Shaanxi Daily reported a RMB 113 million cooperation project covering hot-runner molds and automated retractable self-disable syringe lines.
View public source ↗2026.0104Shaanxi Medical Products Administration listed a Class II registration for a single-use human venous blood specimen collection container under the company name.
View public source ↗Quality and intellectual property
View the ISO 13485 quality management system certificate and selected international patent documents supplied by Xingxu Kangda.

Certificate No. 05135233 0001 Rev. 00. Scope includes the design, development, production and distribution of disposable sterile retractable self-destructing syringes.
View original PDF →
Safe syringe patent document; proprietor shown on original: LU, WEN-CHIN.
View original PDF →
Patent IDP000069186 - SAFE SYRINGE; proprietor shown on original: LU, WEN-CHIN.
View original PDF →
European patent procedure document supplied for safe syringe technology.
View original PDF →
Brevet d'Invention No. 18823 - Safe syringe; proprietor shown on original: LU, WEN-CHIN.
View original PDF →